Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/Δ32ccr5 heterozygotes

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 4, 1997, Pages 243-246

  Edelstein, Reva E ^a   Manns Arcuino, Laura A ^a   Hughes, James P ^b   Melvin, Ann J ^a   Mohan, Kathleen M ^a   King, Peggy D ^a   McLellan, Connie L ^a   Murante, Barbra L ^c   Kassman, Barbara P ^c   Frenkel, Lisa M ^a,c,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

CCR5 receptor; Pediatrics; Vertical transmission

Indexed keywords

CHEMOKINE RECEPTOR; ZIDOVUDINE;

ARTICLE; CHILD; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12644258518     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199712010-00004     Document Type: Article

References (19)

1. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
2. Choe H, Farzan M, Sun Y, et al. The B-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
3. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.
4. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. J Virol 1993;197:624-9.
5. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk exposures. Nature Medicine 1996; 2:412-7.
6. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
7. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Medicine 1997;3:338-40.
8. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
9. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-5.
10. Chakraborty R, Smouse PE. Recombination of haplotypes leads to biased estimates of admixture proportions in human populations. Proc Natl Acad Sci USA 1988;85:3071-4.
11. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type I from mother to infant. N Engl J Med 1996;335:1621-9.
12. Boyer PJ, Dillon M, Navaie M et al. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994;271: 1925-30.
13. Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994;272: 467-74.
14. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type I from mother to child. N Engl J Med 1996;334:1617-23.
15. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994;331:1173-80.
16. Zack JA, Haislip AM, Krogstad P, Chen ISY. Incompletely reverse transcribed human immunodeficiency virus type I genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992;66:1717-25.
17. Baptista J, Pike MC. Exact two-sided confidence limits for the odds ration in a 2 × 2 table. Appl Stat 1977;26:214-20.
18. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 1995, no. 2. Atlanta: Centers for Disease Control and Prevention, 1995:7.
19. Rousseau CM, Just JJ, Abrams EJ, et al. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:239-42.